Turkmenistan TDS Mandatory Certification for Medical Devices: Scope and Differences from National Registration

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Turkmenistan applies mandatory certification to imported products under the Certification Law; the market commonly calls it TDS (conformity assessment under the national system of standards and certification of Turkmenistan).

The core judgment: mandatory TDS certification and national registration by the Ministry of Health are 2 parallel lines that cannot replace each other, and the differences appear in 4 aspects:

  • Different legal basis — the Certification Law versus the Law on the Supply of Medicines No. 319-V;
  • Different receiving bodies — the system of standards and certification versus the Ministry of Health and its national center;
  • Different object of evaluation — product or batch versus product model;
  • Different use of the result — clearance and circulation versus the qualification for placing on the market and use.

2. Legal basis

Legal instrumentReference or numberPublication dateProvisions
Certification Law of TurkmenistanNo public numberCurrent versionMandatory conformity assessment and certification
Law of Turkmenistan on the Supply of MedicinesNo. 319-VJanuary 12, 2016National registration (parallel to certification)

3. Expert insights

Insight 1: Treating the two lines as one is the most common planning error in this market.

If a company budgets and schedules only for national registration, it will discover close to the shipping date that another certification line must be run and another fee paid. The correct approach is to place both lines side by side in the Gantt chart at project start. The omission is understandable: most markets the company already serves ask for either registration or certification, rarely both. Turkmenistan asks for both, and the two lines are administered by bodies that do not coordinate their calendars, so only the applicant’s own plan can keep them synchronized.

Insight 2: The two lines follow different evaluation logics, and documents cannot simply be reused.

National registration looks at safety, quality, and effectiveness (the perspective of the Pharmacopoeia Committee and the national center); mandatory certification looks at conformity with the national standards and technical regulations of Turkmenistan. The same test report may serve both sides, but the manner of presentation and the emphasis differ. A well-organized project therefore maintains a single evidence library with two view maps: one index organized by the registration dossier structure, and one index organized by the standard clauses relevant to certification, so the same underlying report can be compiled quickly for each audience without rework.

Insight 3: Requirements such as electrical safety under the Certification Law are an additional threshold for devices.

A note from practical estimate: in the certification stage, imported devices may be required to comply with electrical safety and other requirements in the national standards of Turkmenistan. This item is not prominent in the checklist of national registration documents, yet it can become the blocking point of the certification stage. Manufacturers of powered equipment should gather their IEC test reports and declarations early, map them against the Turkmen standards invoked by the certification body, and identify gaps while there is still time to test, because retrofitting electrical evidence after a consignment is booked is one of the most expensive forms of rework in this market.

Insight 4: Certification documents face the same questions of validity and renewal.

Unlike the 5-year validity of the national registration certificate, certification is usually issued per batch or per contract. This means it is a matter to remember with every shipment, not a matter to remember once in five years. Operationally, this changes who owns the task: certification belongs to the logistics and quality functions on a per-consignment basis, not to the regulatory team on a five-year cycle. Companies that leave it with the regulatory team alone often find that no one noticed the expiry of a certificate that the shipping department assumed was someone else’s responsibility.

Insight 5: When the progress of the two lines diverges, the cost lands in warehousing and tied-up capital.

If national registration is completed first and certification lags, the goods reach the port but cannot be cleared, and the result is demurrage and storage cost. Parallel execution is not only about speed; it is above all about avoiding this mismatch. The financial exposure is easy to underestimate: port storage, container detention, rebooking fees, and customer penalties accumulate daily, and in government-driven markets a missed delivery window may push the consignment into the next procurement year. A modest overlap of the two schedules is the cheapest insurance available.

4. Practical recommendations

  1. Place TDS certification and national registration side by side in the schedule from project start.
  2. Organize documents separately for the different emphases of the two lines and do not copy them blindly.
  3. Confirm in advance the applicability of the national standards of Turkmenistan, such as electrical safety (practical estimate).
  4. Obtain certification per batch or per contract and make it a routine action of every shipment.
  5. Align the progress of the two lines to avoid the mismatch of goods that cannot be cleared on arrival.

5. Verification checklist

  • □ The Gantt chart has placed the 2 lines side by side (TDS certification and national registration).
  • □ Documents have been organized separately for the two lines.
  • □ The applicability of national standards such as electrical safety has been confirmed.
  • □ Obtaining certification per batch or contract has been integrated into the shipping process.
  • □ The progress of the two lines is aligned to avoid port demurrage.

Regulatory information verified as of October 30, 2026. The content cited in this document has been checked against the Certification Law of Turkmenistan (current version, mandatory conformity assessment of imported products) and the Law of Turkmenistan on the Supply of Medicines No. 319-V (January 12, 2016); the specific product catalogue, procedure, fee schedule, and the applicability of national standards such as electrical safety under TDS certification have not been obtained in official text, are a practical estimate, and must be confirmed case by case with the competent authority for standards and certification of Turkmenistan.

  • Local resources in Turkmenistan: GRZAN can coordinate licensed local import entities and authorized representative resources, covering national registration submissions, the consular legalization chain for documents, sample delivery, interface with mandatory TDS certification, and customs clearance support.
  • Service capabilities: classification assessment, registration pathway selection, national-format dossier writing, notarization and consular legalization, preparation of test and stability documentation, organization of GMP and ISO 13485 evidence, variations and renewal, vigilance and post-market maintenance.
  • Contact: info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail